228 related articles for article (PubMed ID: 8625962)
61. CD6-ligand interactions: a paradigm for SRCR domain function?
Aruffo A; Bowen MA; Patel DD; Haynes BF; Starling GC; Gebe JA; Bajorath J
Immunol Today; 1997 Oct; 18(10):498-504. PubMed ID: 9357143
[TBL] [Abstract][Full Text] [Related]
62. Differential expression and regulation of CD6 on T-cell subsets revealed by monoclonal antibody (MAb) CH11.
Bank I; Dardik R; Levy V; Goldstein I; Shoham J
Hybridoma; 2001 Apr; 20(2):75-84. PubMed ID: 11394533
[TBL] [Abstract][Full Text] [Related]
63. Long-term engagement of CD6 and ALCAM is essential for T-cell proliferation induced by dendritic cells.
Zimmerman AW; Joosten B; Torensma R; Parnes JR; van Leeuwen FN; Figdor CG
Blood; 2006 Apr; 107(8):3212-20. PubMed ID: 16352806
[TBL] [Abstract][Full Text] [Related]
64. Extracellular isoforms of CD6 generated by alternative splicing regulate targeting of CD6 to the immunological synapse.
Castro MA; Oliveira MI; Nunes RJ; Fabre S; Barbosa R; Peixoto A; Brown MH; Parnes JR; Bismuth G; Moreira A; Rocha B; Carmo AM
J Immunol; 2007 Apr; 178(7):4351-61. PubMed ID: 17371992
[TBL] [Abstract][Full Text] [Related]
65. Mitogen-activated protein kinase pathway activation by the CD6 lymphocyte surface receptor.
Ibáñez A; Sarrias MR; Farnós M; Gimferrer I; Serra-Pagès C; Vives J; Lozano F
J Immunol; 2006 Jul; 177(2):1152-9. PubMed ID: 16818773
[TBL] [Abstract][Full Text] [Related]
66. Activation of human T cells through CD6: functional effects of a novel anti-CD6 monoclonal antibody and definition of four epitopes of the CD6 glycoprotein.
Bott CM; Doshi JB; Morimoto C; Romain PL; Fox DA
Int Immunol; 1993 Jul; 5(7):783-92. PubMed ID: 7690243
[TBL] [Abstract][Full Text] [Related]
67. Domain-specific CD6 monoclonal antibodies identify CD6 isoforms generated by alternative-splicing.
Santos RF; Oliveira L; Brown MH; Carmo AM
Immunology; 2019 Aug; 157(4):296-303. PubMed ID: 31162836
[TBL] [Abstract][Full Text] [Related]
68. Phenotypic and functional characterization of the CD6-ALCAM T-cell co-stimulatory pathway after allogeneic cell transplantation.
Rambaldi B; Kim HT; Arihara Y; Asano T; Reynolds C; Manter M; Halpern M; Weber A; Koreth J; Cutler C; Gooptu M; Nikiforow S; Ho VT; Antin JH; Romee R; Ampudia J; Ng C; Connelly S; Soiffer RJ; Ritz J
Haematologica; 2022 Nov; 107(11):2617-2629. PubMed ID: 35484649
[TBL] [Abstract][Full Text] [Related]
69. Rationale for treating primary Sjögren's syndrome patients with an anti-CD6 monoclonal antibody (Itolizumab).
Le Dantec C; Alonso R; Fali T; Montero E; Devauchelle V; Saraux A; Pers JO; Renaudineau Y
Immunol Res; 2013 Jul; 56(2-3):341-7. PubMed ID: 23576060
[TBL] [Abstract][Full Text] [Related]
70. Role of the CD6 glycoprotein in antigen-specific and autoreactive responses of cloned human T lymphocytes.
Singer NG; Richardson BC; Powers D; Hooper F; Lialios F; Endres J; Bott CM; Fox DA
Immunology; 1996 Aug; 88(4):537-43. PubMed ID: 8881754
[TBL] [Abstract][Full Text] [Related]
71. CD6 dependent interactions of T cells and keratinocytes: functional evidence for a second CD6 ligand on gamma-interferon activated keratinocytes.
Singer NG; Mitra R; Lialios F; Richardson BC; Marks RM; Pesando JM; Fox DA; Nickoloff BJ
Immunol Lett; 1997 Jun; 58(1):9-14. PubMed ID: 9436462
[TBL] [Abstract][Full Text] [Related]
72. Expression and characterization of a novel CD6 ligand in cells derived from joint and epithelial tissues.
Saifullah MK; Fox DA; Sarkar S; Abidi SM; Endres J; Piktel J; Haqqi TM; Singer NG
J Immunol; 2004 Nov; 173(10):6125-33. PubMed ID: 15528349
[TBL] [Abstract][Full Text] [Related]
73. CD6 modulates thymocyte selection and peripheral T cell homeostasis.
Orta-Mascaró M; Consuegra-Fernández M; Carreras E; Roncagalli R; Carreras-Sureda A; Alvarez P; Girard L; Simões I; Martínez-Florensa M; Aranda F; Merino R; Martínez VG; Vicente R; Merino J; Sarukhan A; Malissen M; Malissen B; Lozano F
J Exp Med; 2016 Jul; 213(8):1387-97. PubMed ID: 27377588
[TBL] [Abstract][Full Text] [Related]
74. Modulation of CD6 function through interaction with Galectin-1 and -3.
Escoda-Ferran C; Carrasco E; Caballero-Baños M; Miró-Julià C; Martínez-Florensa M; Consuegra-Fernández M; Martínez VG; Liu FT; Lozano F
FEBS Lett; 2014 Aug; 588(17):2805-13. PubMed ID: 24945728
[TBL] [Abstract][Full Text] [Related]
75. Multifaceted effects of soluble human CD6 in experimental cancer models.
Simões IT; Aranda F; Casadó-Llombart S; Velasco-de Andrés M; Català C; Álvarez P; Consuegra-Fernández M; Orta-Mascaró M; Merino R; Merino J; Alberola-Ila J; González-Aseguinolaza G; Carreras E; Martínez V; Lozano F
J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32217757
[TBL] [Abstract][Full Text] [Related]
76. CD6: expression during development, apoptosis and selection of human and mouse thymocytes.
Singer NG; Fox DA; Haqqi TM; Beretta L; Endres JS; Prohaska S; Parnes JR; Bromberg J; Sramkoski RM
Int Immunol; 2002 Jun; 14(6):585-97. PubMed ID: 12039910
[TBL] [Abstract][Full Text] [Related]
77. Relevance of CD6-mediated interactions in T cell activation and proliferation.
Gimferrer I; Calvo M; Mittelbrunn M; Farnós M; Sarrias MR; Enrich C; Vives J; Sánchez-Madrid F; Lozano F
J Immunol; 2004 Aug; 173(4):2262-70. PubMed ID: 15294938
[TBL] [Abstract][Full Text] [Related]
78. Epitope mapping of anti-rat CD53 monoclonal antibodies. Implications for the membrane orientation of the Transmembrane 4 Superfamily.
Tomlinson MG; Williams AF; Wright MD
Eur J Immunol; 1993 Jan; 23(1):136-40. PubMed ID: 7678222
[TBL] [Abstract][Full Text] [Related]
79. A monoclonal antibody (HML-1) defining a novel membrane molecule present on human intestinal lymphocytes.
Cerf-Bensussan N; Jarry A; Brousse N; Lisowska-Grospierre B; Guy-Grand D; Griscelli C
Eur J Immunol; 1987 Sep; 17(9):1279-85. PubMed ID: 3498635
[TBL] [Abstract][Full Text] [Related]
80. CD6 monoclonal antibodies differ in epitope, kinetics and mechanism of action.
Garner LI; Hartland A; Breuning J; Brown MH
Immunology; 2018 Oct; 155(2):273-282. PubMed ID: 29772075
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
